Location: Home
  • search
  • go
  • Relate News
  • 3/21/2025NHSA Releases Its 2024 Statistical Bulletin on Healthcare Security De...
  • 3/21/2025Gilead's Trodelvy Receives Second Approval in China
  • 3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...
  • 3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials
  • 3/21/2025Junshi's Toripalimab Receives 11th Approval in China
  • 3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China
  • 3/21/2025Recent Executive Moves
  • 3/21/2025Visen Pharma Debuts on Hong Kong Stock Exchange
  • 3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China
  • 3/20/2025NMPA Seeks Public Feedback on Draft Guidelines for Drug Trial Data Pro...
  • 3/20/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (92...
  • 3/20/2025Chinese Government Issues Notice on Strengthening Drug Traceability Co...
  • 3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...
  • 3/19/2025Accropeutics Secured $12M in Series B Plus Financing
  • 3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...
  • 3/19/2025Celregen Secures ~CNY 100M in Angel+ Financing
  • 3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients
  • 3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS
  • 3/19/2025Teva and Kerry Form Strategic Partnership to Strengthen Pharma Supply ...
  • 3/19/2025EU Chamber Urges China to Balance Drug Procurement Priorities amid Pri...
  • 3/19/2025CDE Issues the 2024 Annual Drug Evaluation Report with Record Surge in...
  • 3/19/2025MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...
  • 3/19/2025Shanghai Breaks Ground on National Emergency Medical Center
  • 3/19/2025Rona Thera Secures $25M in Series Pre-B Financing to Advance siRNA The...
  • 3/19/2025These 12 Chinese Companies Are Poised to Transform CRISPR Gene-Editing...
  • 3/19/2025China's Healthcare Sector in 2025: Anti-Corruption and Beyond (CR)
  • 3/19/2025Trends and Projections of Hypertensive Heart Disease Burden in China: ...
  • 3/19/2025Severe Decline in County Market in 2024, Possible Rebound in 2025, wit...
  • 3/17/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...
  • 3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...
  • Page:8/764 Total number of articles:22895: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group